IQWiG Autumn Symposium 2010
Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms
How can the benefits and harms of interventions in different medical areas be balanced against each other? How evidence-based can such a balancing be? How do the approaches to such a balancing of benefits and harms differ from the perspective of the German Drug Law on the one hand and that of the Social Code Book on the other? Which study data are required to be able to actually perform an informed balancing of benefits and harms? For example, how is the development of clinical practice guidelines affected if only part of the study data is available? What about data transparency in the field of medical devices? Leading health care researchers will discuss these and other questions at IQWiG's annual Autumn Symposium in Cologne on 19 and 20 November.
As in the last years all presentations can be viewed as audiovisual presentations on the IQWiG website.